INTRODUCTION
Previous studies of the host response to infection with group A f-hemolytic streptococci in man have demonstrated that patients with acute rheumatic fever (ARF)1
Received for publication 21 March 1974 and in revised form 5 June 1974. 'Abbreviations used in this paper: A-antibody, antibody to group A streptococcal cell wall carbohydrate; AGN, acute glomerulonephritis; anti-DNase B, anti-deoxyribonuand acute glomerulonephritis (AGN) manifest elevated serum antibody titers to a wide variety of streptococcal antigens (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . These findings have provided the major evidence establishing the fact that group A streptococcal infection is related to the pathogenesis of these two diseases. While quantitative differences in the magnitude of the antibody responses to various streptococcal extracellular antigens in patients with ARF and AGN have been found during the acute stages of these diseases, available data have not supported a definitive role for the antibodies to these extracellular products in the pathogenesis of the nonsuppurative streptococcal sequelae (11) . Although studies of the antibody response to group A streptococcal cell wall carbohydrate have shown little difference in magnitude of response in patients with ARF and AGN (6, 8) , the persistence of elevated levels of antibody to group A streptococcal cell wall carbohydrate (A-antibody) in sera of patients with chronic inactive rheumatic valvular heart disease has suggested a pathogenetic relationship (8, 12) .
The lack of striking differences in the quantitative aspects of the antibody response to streptococcal antigens among patients with ARF and AGN prompted our investigation of certain qualitative aspects of serum A-antibody in these individuals. Prior studies have demonstrated that one qualitative parameter, antibody affinity, could be assessed by using an antigenically univalent radiolabeled hapten (a hapten) prepared from group A streptococcal carbohydrate (A-carbohydrate) (13) . The present study was undertaken to investigate the possible presence of differences in affinity of serum A-antibody during the acute stages of ARF, AGN, and following uncomplicated streptococcal infection. In addition, the clease B; ARF, acute rheumatic fever; ASO, anti-streptolysin 0; K., average association constant; LCM, lymphocytic choriomeningitis; PCA, passive cutaneous anaphylaxis.
The Journal of Clinical Investigation Volume 54 October 1974.990-996 990 molar concentration of A-antibody binding sites was determined (13) , and the relative influence of the average association constant (Ko)and binding site concentration upon the A-antibody level was also studied. METHODS Sera. Sera were obtained from three groups of patients seen in the hospitals and clinics of the University of Florida. Serum specimens were drawn from 29 patients, ages 4-16 yr (mean, 10.7 yr), early in the course of ARF. Only those patients clearly fulfilling the modified Jones Criteria (14) for the diagnosis of ARF were included. 16 of these children had cardiac mitral valvular involvement at the time of study. Sera from 16 children (4-17 yr; mean, 8.8 yr) with poststreptococcal AGN were obtained shortly after presentation to the hospital. Seven of the AGN patients had historical or clinical evident of antecedent impetigo without history of recent pharyngitis, four had recent pharyngitis only, while three patients had had both impetigo and pharyngitis. Of the remaining two patients, one had had a subcutaneous streptococcal abscess and the other had no clinical evidence of recent streptococcal infection. In addition, sera of 16 patients (2-23 yr; mean, 12.3 yr) with documented recent group A streptococcal infection uncomplicated by nonsuppurative sequelae were studied. This category included patients with streptococcal pharyngitis, cellulitis, or lymphadenitis; no patients with impetigo alone were included.
Sera of patients with streptococcal infection were selected in part on the basis of elevated A-antibody levels, since A-antibody binding studies require a significant degree of antibody activity. Sera were obtained 3-8 wk following streptococcal infection, so that the interval between infection and bleeding would approximate that of the ARF and AGN patients.
Sera were processed aseptically and stored at -10'C until studied. All assays were performed in groups including proportionate numbers of sera from each category.
Antibody determinations. Anti-streptolysin 0 (ASO) and anti-deoxyribonuclease B (anti-DNase B) titers were measured by the micromethods previously described (15, 16 Measurement of A-antibody affinity. Antibody affinity, expressed as the Ko value for the reaction between serum A-antibody and the univalent tritium-labeled a hapten, was measured as previously described (13) . By this method, the concentration of free (unbound) a hapten is determined by measurement of the radioactivity in the supernatant fluid after precipitation of globulins with half-saturated ammonium sulfate. The concentration of specifically bound a hapten is determined from radioactivity counts in the washed precipitates, with subtraction of background hapten binding by normal rabbit serum. By using the method of Sips [as detailed by Karush (17) ], Ko values are calculated from plots of the free and specifically bound hapten concentrations obtained when varying concentrations of a hapten are reacted with constant amounts of serum. The majority of studies were performed in duplicate. Binding studies were performed with whole serum instead of with purified A-antibody in order to eliminate the possible selection of higher affinity antibody molecules during the isolation of A-antibody by immunoadsorbent techniques (18) .
Quantitation of A-antibody binding sites. By using the a hapten, the molar concentration of antibody binding sites was determined from binding data as previously described (13) . For each serum, increasing concentrations of hapten yielded specific hapten binding which approached a maximum level, reflecting saturation of antibody binding sites. Molarity of antibody binding sites was derived by extrapolation of the binding curve to infinite concentration of hapten added.
RESULTS
Anti-streptococcal antibody values. ASO and antiDNase B titers, as well as A-antibody levels, were assayed on sera from the 29 patients with ARF, 16 with AGN, and 16 with uncomplicated streptococcal infection. As seen in Fig. 1 , the ASO titers of the ARF patients were significantly higher (P < 0.01) than those of patients with AGN or those following uncomplicated streptococcal infection. No appreciable difference in ASO titers was apparent between the two nonrheumatic groups. By contrast, the anti-DNase B titers of both the ARF and the AGN patients were found to be significantly higher than those of the streptococcal infection category (P < 0.001 and P <0.01, respectively). No significant difference in anti-DNase B was observed between the AGN and ARF groups. When the A-antibody levels of these three groups were compared, findings similar to those noted for the ASO titers were observed, in that significantly higher levels of A-antibody were found in the ARF group as compared with the AGN and infection groups (P < 0.01 and P < 0.001, respectively).
Studies of A-antibody affinity. Binding studies with a hapten and patient sera yielded Ko values shown in Fig. 2 . Mean Ko values ± standard deviations, as well as mean A-antibody levels and A-antibody binding site concentrations for the three study groups, are recorded in Table I . When Ko values determined for sera of ARF patients (mean = 4.13 X 10' liters/M) were compared to the values for sera of AGN patients (mean = 5.97 X 10' liters/M), significant differences were obtained (P < 0.02). Likewise, comparison of ARF values with those of the streptococcal infection group (mean = 7.64 X 10' liters/M) revealed highly significant differences (P < 0.001). No significant difference was found between Kos of the AGN and streptococcal infection sera. Thus, serum A-antibody of ARF patients is of lower affinity than the A-antibody present in the serum of patients with .N S -a-. (Table I ) with the group means of A-antibody binding site concentrations yielded a highly positive correlation (r = + 0.99; P <0.001). Further analysis was performed to determine whether the same high degree of correlation yielded by the mean values would be obtained with the individual values. The relationship between these two parameters for individual serum specimens is shown in Fig. 3 , in which the radioimmune precipitin A-antibody level is plotted against antibody site concentration. As can be seen, there is a strong positive correlation between these measurements, with r = + 0.91 (P < 0.001). This positive correlation was apparent for each of the categories examined. The possible influence of A-antibody K. upon the radioimmune precipitin A-antibody level was also evaluated by plotting A-antibody levels against the Sips Ko values determined for individual serum samples (Fig. 4) . As can be seen, little correlation between these functions was found, with r = -0.25. figure. nomenon of increasing antibody affinity with time after immunization, an association which has been described in a number of animal studies (19) . To control this variable, careful attention was given to the interval between streptococcal infection and bleeding. Sera from the streptococcal infection patients were obtained 3-8 wk following streptococcal infection to correspond approximately to the presumed interval between streptococcal infection and bleeding among the patients with ARF and AGN, from whom sera in general were obtained 1-3 wk following the onset of the poststreptococcal sequelae.
The fact that the observed differences in K. between the ARF and streptococcal infection groups are independent of A-antibody concentration is demonstrated by the data in Table II . These data show that when Kes of sera closely matched in terms of A-antibody concentration were compared, highly significant differences in K. among rheumatic and nonrheumatic individuals were found. Since hapten binding studies require the use of serum containing high levels of antibody, the streptococcal infection sera selected for this study contained elevated A-antibody levels. Despite this selection bias, the lowest titers of all three antistreptococcal antibodies measured in the present study were found among the streptococcal infection group, probably reflecting the influence of antibiotic therapy (20, 21) . The quantitative difference in mean ASO titer observed among the ARF patients and the nonrheumatic groups (P < 0.01) conforms with previous studies which also demonstrated higher mean ASO titers among patients developing ARF than among patients in whom nonsuppurative sequelae did not develop after streptococcal infection (1, 2, 7, 22, 23) . The higher mean ASO titer previously observed among AGN patients as compared to an ARF group (4) may reflect the fact that all AGN patients in the previous study had had pharyngitis as the antecedent streptococcal infection. This circumstance contrasts with the present study in which about one-half of the AGN patients had postimpetigo nephritis, which has been shown to be less frequently associated with ASO elevation (24) . The anti-DNase B titers in the present study are comparable to those previously reported in that the highest mean titer was found in ARF patients, the next highest in the AGN group, and the lowest mean titer in patients following uncomplicated streptococcal infection (4, 8) .
In addition to these quantitative differences in antibodies to streptococcal extracellular products, A-antibody levels were higher among the ARF patients in the present study than in the AGN and streptococcal infection patient groups. The discrepancy between the present findings and those from previous studies may be explained by variations in technique. Using the radioimmune precipitin technique, Dudding and Ayoub (8) found no significant difference in A-antibody values among patients with ARF and AGN. The finding of higher A-antibody values among the ARF group than among the AGN patients in the present study may reflect the modification of the A-antibody assay used, by which the dilution of serum enabled differences in high levels of A-antibody to become apparent.
The degree of influence of antibody affinity upon the radioimmune precipitin assay employing [G'C]A-carbo- In addition, it was demonstrated that there was little and the 13 patients without obvious heart disease showed influence of antibody K. upon the radioimmune precipi-a higher mean K. in patients with carditis (P > 0.02). tin assay. This finding would appear to provide defini-However, exclusion of two extremely low K. values tive documentation supporting the impression that the obtained for determinations on two patients without radioimmune precipitin procedure, which involves pri-heart disease yielded means which were not significantly mary interaction of antigen and antibody, predominantly different (P = 0.07). This comparison is of particular reflects concentration of antibody binding sites and, interest in view of the suggested relationship between within the range of antibody affinity encountered, is valvular glycoprotein and antibody to the group A carboindependent of K.. This independence contrasts with the hydrate (27) , a relationship which raises the possibility results of secondary and tertiary antibody assays in which that high affinity antibody might be removed by adsorpqualitative parameters of antibody such as affinity as-tion to this cross-reactive antigen. Although the present sume great importance (25) . It should be noted in this data do not support this hypothesis, the limited number respect that workers using a hemagglutination technique of patients involved in this comparison, as well as the reported that A-antibody titers were elevated to a com-difficulty in differentiating primary valvulitis from valparable degree in ARF and AGN patients (6), while vular insufficiency secondary to dilatation of the ananother group using the same technique found A-anti-nulus during the acute stage of rheumatic fever, do not body levels to be elevated among AGN but not among allow for any conclusions. Long-term follow-up studies ARF patients (26) . The direct comparison of an anti-should enable elucidation of any such differences in body assay reflecting primary antigen-antigen binding, antibody affinity between patients with or without prisuch as the radioimmune precipitin reaction, with one mary rheumatic valvulitis. dependent upon secondary or tertiary phenomena, such Assessment of A-antibody affinity was undertaken beas hemagglutination, may be misleading (25) .
cause of the increasing awareness of the role of antibody
The finding of serum A-antibody of low affinity among affinity in the humoral immune response. As pointed out rheumatic patients may represent an isolated immuno-by Siskind and Benacerraf (19) , antibody affinity may logic phenomenon involving the A-carbohydrate-A-anti-well be of greater relevance than quantity of antibody body system. This possibility may be supported by the since there exists a wider range of affinities than of antifinding of in vitro differences in cell-mediated immunity body quantity and since most biological phenomena into group A carbohydrate but not to group C carbohydrate volving antigen-antibody reactions in vivo occur at low or to group A mucopeptide among acute rheumatic pa-antigen concentrations. That differences in antibody affintients.' Such an isolated phenomenon could result from ity may have biological significance was first established the primary synthesis of low-affinity A-antibody by rheu-by the demonstration that the guinea pig passive cutanematic individuals or secondarily from the removal of ous anaphylaxis (PCA) response could be shown to higher affinity A-antibody molecules in the form of im-depend upon antibody affinity (28, 29) . Thus, high-affinmune complexes, resulting in serum antibody molecules ity antibody was found to be significantly more effective of relatively low average association constant. The than low-affinity antibody in producing PCA reactions. primary synthesis of low-affinity A-antibody might oc-Similarly, the recent work of Soothill, Steward, Alpers, cur as the result of a defect in antigenic processing mech-and Petty (30) (31) (32) has demonstrated a relationship beanisms, or could represent the influence of antigenic dose tween affinity of antibody synthesized by mice of varior state upon the quality of antibody synthesized. For ous strains and the relative susceptibility of these example, it has been demonstrated in experimental ani-strains to the immune complex nephritis of chronic mals that lower affinity antibody is induced by the ad-lymphocytic choriomeningitis (LCM) virus infection. ministration of higher doses of antigen and that soluble These workers showed that the mouse strains with the antigens have the capacity to render high-affinity anti-highest incidence of LCM nephritis were the very strains body-producing cells selectively unresponsive (19) . Al-which produced the lowest affinity antibody and which ternatively, the low-affinity antibody observed among could be shown to demonstrate the least efficient immune rheumatic individuals in the present study may be a elimination. While the biologic significance of the difmanifestation of a generalized immunochemical differ-ferences in K. values among the several patient groups in ence in the nature of antibody synthesized by these pa-the present study has not been established, these differ-'M. L. Schulkind 
